These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 8490172)
1. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blinc A; Francis CW; Trudnowski JL; Carstensen EL Blood; 1993 May; 81(10):2636-43. PubMed ID: 8490172 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of fibrinolysis in vitro by ultrasound. Francis CW; Onundarson PT; Carstensen EL; Blinc A; Meltzer RS; Schwarz K; Marder VJ J Clin Invest; 1992 Nov; 90(5):2063-8. PubMed ID: 1430229 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of fibrinolysis with 40-kHz ultrasound. Suchkova V; Siddiqi FN; Carstensen EL; Dalecki D; Child S; Francis CW Circulation; 1998 Sep; 98(10):1030-5. PubMed ID: 9737524 [TBL] [Abstract][Full Text] [Related]
4. Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone. Härdig BM; Carlson J; Roijer A BMC Cardiovasc Disord; 2008 Aug; 8():19. PubMed ID: 18727834 [TBL] [Abstract][Full Text] [Related]
5. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Francis CW; Blinc A; Lee S; Cox C Ultrasound Med Biol; 1995; 21(3):419-24. PubMed ID: 7645133 [TBL] [Abstract][Full Text] [Related]
6. Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1. Li XK; Lijnen HR; Nelles L; Van Hoef B; Stassen JM; Collen D Blood; 1992 Jan; 79(2):417-29. PubMed ID: 1730087 [TBL] [Abstract][Full Text] [Related]
7. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro. Cassels R; Fears R; Smith RA Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of staphylokinase, streptokinase and tissue-type plasminogen activator on the lysis of retracted human plasma clots and fibrinolytic plasma parameters in vitro. Hauptmann J; Glusa E Blood Coagul Fibrinolysis; 1995 Sep; 6(6):579-83. PubMed ID: 7578902 [TBL] [Abstract][Full Text] [Related]
9. Ultrasound enhancement of fibrinolysis at frequencies of 27 to 100 kHz. Suchkova V; Carstensen EL; Francis CW Ultrasound Med Biol; 2002 Mar; 28(3):377-82. PubMed ID: 11978418 [TBL] [Abstract][Full Text] [Related]
10. Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitro. Samama M; Nguyen G; Desnoyers P; Lourenco DM; Fretault J; Horellou MH; Conard J; Szwarcer E; Verdy E; Vahanian A Fundam Clin Pharmacol; 1988; 2(6):509-23. PubMed ID: 3149257 [TBL] [Abstract][Full Text] [Related]
11. Effect of ultrasound on enzymatic activity of selected plasminogen activators. Soltani A; Soliday C Thromb Res; 2007; 119(2):223-8. PubMed ID: 16545433 [TBL] [Abstract][Full Text] [Related]
12. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro. Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448 [TBL] [Abstract][Full Text] [Related]
14. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators. Sabovic M; Lijnen HR; Keber D; Collen D Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603 [TBL] [Abstract][Full Text] [Related]
15. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro. Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946 [TBL] [Abstract][Full Text] [Related]
16. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA). Trusen B; Ries M; Zenker M; Rauh M; Beinder E; Keuper H; Harms D Semin Thromb Hemost; 1998; 24(6):599-604. PubMed ID: 10066156 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasonic irradiation: in vitro experiment involving assay of the fibrin degradation products from the clot. Kimura M; Iijima S; Kobayashi K; Furuhata H Biol Pharm Bull; 1994 Jan; 17(1):126-30. PubMed ID: 8148800 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of the effect of ultrasound on the fibrinolysis of clots. Chernysh IN; Everbach CE; Purohit PK; Weisel JW J Thromb Haemost; 2015 Apr; 13(4):601-9. PubMed ID: 25619618 [TBL] [Abstract][Full Text] [Related]
20. Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential. Onundarson PT; Francis CW; Marder VJ J Lab Clin Med; 1992 Jul; 120(1):120-8. PubMed ID: 1613318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]